Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fahnoe, Kelly C.
21  Ergebnisse:
Personensuche X
?
1

C3d-Targeted factor H inhibits tissue complement in disease..:

Liu, Fei ; Ryan, Sarah T. ; Fahnoe, Kelly C....
Molecular Therapy.  32 (2024)  4 - p. 1061-1079 , 2024
Link: https://doi.org/10.1016/..
 
?
2

103 C3d-Directed Factor H Delivers Potent and Durable Local..:

Liu, Fei ; Ryan, Sarah T ; Fahnoe, Kelly C...
Immunobiology.  228 (2023)  5 - p. 152554 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Development and Optimization of Bifunctional Fusion Protein..:

Fahnoe, Kelly C. ; Liu, Fei ; Morgan, Jennifer G....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Non-Traditional Antibacterial Screening Approaches for the ..:

Fahnoe, Kelly C. ; Flanagan, Mark E. ; Gibson, Glenn...
PLoS ONE.  7 (2012)  12 - p. e51732 , 2012
Link: https://doi.org/10.1371/..
 
?
5

Development and Optimization of Bifunctional Fusion Protein..:

Fahnoe, Kelly C ; Liu, Fei ; Morgan, Jennifer G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244803/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Clinically Relevant Gram-Negative Resistance Mechanisms Hav..:

McPherson, Craig J ; Aschenbrenner, Lisa M ; Lacey, Brian M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497185.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
7

The design and synthesis of human branched-chain amino acid..:

Hu, Lain-Yen ; Boxer, Peter A. ; Kesten, Suzanne R....
Bioorganic & Medicinal Chemistry Letters.  16 (2006)  9 - p. 2337-2340 , 2006
Link: https://doi.org/10.1016/..
 
?
8

Image_2_Development and Optimization of Bifunctional Fusion..:

Kelly C. Fahnoe ; Fei Liu ; Jennifer G. Morgan...
doi:10.3389/fimmu.2022.869725.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
9

Development and Optimization of Bifunctional Fusion Protein..:

Kelly C. Fahnoe ; Fei Liu ; Jennifer G. Morgan...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.869725/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

Image_1_Development and Optimization of Bifunctional Fusion..:

Kelly C. Fahnoe ; Fei Liu ; Jennifer G. Morgan...
doi:10.3389/fimmu.2022.869725.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

Non-traditional antibacterial screening approaches for the ..:

Kelly C Fahnoe ; Mark E Flanagan ; Glenn Gibson...
http://europepmc.org/articles/PMC3519852?pdf=render.  , 2012
Link: https://doi.org/10.1371/..
 
?
12

Inhibitor Potencies and Substrate Preference for Endothelin..:

Fahnoe, Douglass C. ; Knapp, Jill ; Johnson, Gary D..
Journal of Cardiovascular Pharmacology.  36 (2000)  Supplement 1 - p. S22-S23 , 2000
Link: https://doi.org/10.1097/..
 
?
13

Inhibitor Potencies and Substrate Preference for Endothelin..:

Fahnoe, Douglass C. ; Knapp, Jill ; Johnson, Gary D..
Journal of Cardiovascular Pharmacology.  36 (2000)  - p. S22-S25 , 2000
Link: https://doi.org/10.1097/..
 
?
14

Disulfide Bonds in Big ET-1 Are Essential for the Specific ..:

Fahnoe, Douglass C. ; Johnson, Gary D. ; Herman, Sarah B..
Archives of Biochemistry and Biophysics.  373 (2000)  2 - p. 385-393 , 2000
Link: https://doi.org/10.1006/..
 
?
15

Soluble Human Endothelin-Converting Enzyme-1: Expression, P..:

Ahn, Kyunghye ; Herman, Sarah B. ; Fahnoe, Douglass C.
Archives of Biochemistry and Biophysics.  359 (1998)  2 - p. 258-268 , 1998
Link: https://doi.org/10.1006/..
 
1-15